Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News ICGS research scientists join to fight against COVID-19 A team of University researchers led by Professor Andrew Beggs is now using the DNA testing facilities within the institute to test for the COVID-19 genome.
Posted 28 May 2020 COVID-19 mortality in cancer patients is not significantly affected by anti-cancer treatments, study finds A new study led by the Universities of Birmingham and Oxford has found the mortality rate in cancer patients who are assessed or treated in hospital with COVID-19 is not significantly affected by anti-cancer treatments.
Posted 21 May 2020 University of Birmingham secures funding for critical UK clinical trial for children diagnosed with rare childhood cancer A team will coordinate the UK arm of a critical European clinical trial which could lead to the development of more effective and kinder treatments for children diagnosed with a rare and aggressive childhood cancer.
Posted 15 May 2020 COVID-19 disruption will lead to 28 million surgeries cancelled worldwide Over 28 million elective surgeries across the globe could be cancelled as a result of the COVID-19 pandemic – leading to patients facing a lengthy wait for their health issues to be resolved, a new study reveals.